NOVEL IMMUNOTHERAPY-BASED CURE INTERVENTIONS
The development of single-pill anti-retroviral therapies (ART) with tolerable toxicity profiles have proven highly effective in suppressing HIV viremia to clinically undetectable levels in people living with HIV (PLWH). However, ART alone is incapable of purging the pool of long-lived, tissue-resident, quiescent CD4+ T-cells harboring latent, replication-competent viral genomes. These ‘viral reservoirs’, maintained despite ART,…